Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.

Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, Miller BL.

Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):365-70. doi: 10.1097/WAD.0b013e3181b5065d.

2.

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT.

Neurology. 2005 Mar 8;64(5):861-5.

PMID:
15753423
3.

Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.

Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T, Takahashi H, Wakabayashi K.

J Neuropathol Exp Neurol. 2003 Aug;62(8):812-9.

PMID:
14503637
4.

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.

Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM.

Neurobiol Dis. 2012 Jan;45(1):188-95. doi: 10.1016/j.nbd.2011.08.003. Epub 2011 Aug 10.

5.

Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.

Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE.

Mov Disord. 2001 Jul;16(4):622-30.

PMID:
11481685
6.

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.

Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF.

Neurology. 2010 Aug 10;75(6):494-9. doi: 10.1212/WNL.0b013e3181ec7fac. Epub 2010 Jul 28.

7.

The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles.

Yoon JH, Lee JE, Yong SW, Moon SY, Lee PH.

Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):151-5. doi: 10.1097/WAD.0000000000000007.

PMID:
24126215
8.

Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment.

Stefanova N, Seppi K, Scherfler C, Puschban Z, Wenning GK.

J Neural Transm Suppl. 2000;(60):335-43. Review.

PMID:
11205151
9.

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.

Jellinger KA.

Biochim Biophys Acta. 2009 Jul;1792(7):730-40. doi: 10.1016/j.bbadis.2008.07.006. Epub 2008 Aug 5. Review.

10.

Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.

Aarsland D.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S144-8. doi: 10.1016/j.parkreldis.2015.09.034. Epub 2015 Sep 21. Review.

PMID:
26411499
11.

Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes.

Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM.

Neurobiol Dis. 2011 Feb;41(2):377-84. doi: 10.1016/j.nbd.2010.10.005. Epub 2010 Oct 14.

PMID:
20951207
12.
13.

When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients.

Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW.

Neurology. 2015 Aug 4;85(5):404-12. doi: 10.1212/WNL.0000000000001807. Epub 2015 Jul 2.

14.

Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.

Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T.

Acta Neuropathol. 2002 Sep;104(3):225-30. Epub 2002 May 9.

PMID:
12172907
15.

Dementia with Lewy bodies.

McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT.

Semin Clin Neuropsychiatry. 2003 Jan;8(1):46-57. Review.

PMID:
12567332
16.

Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y.

Mov Disord. 2004 Jan;19(1):60-7.

PMID:
14743362
17.

Rostral raphe involvement in Lewy body dementia and multiple system atrophy.

Benarroch EE, Schmeichel AM, Sandroni P, Parisi JE, Low PA.

Acta Neuropathol. 2007 Sep;114(3):213-20. Epub 2007 Jul 17.

PMID:
17639427
18.

Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.

Borroni B, Premi E, Formenti A, Turrone R, Alberici A, Cottini E, Rizzetti C, Gasparotti R, Padovani A.

Parkinsonism Relat Disord. 2015 Sep;21(9):1049-55. doi: 10.1016/j.parkreldis.2015.06.013. Epub 2015 Jun 16.

PMID:
26109553
19.

Neuropathology underlying clinical variability in patients with synucleinopathies.

Halliday GM, Holton JL, Revesz T, Dickson DW.

Acta Neuropathol. 2011 Aug;122(2):187-204. doi: 10.1007/s00401-011-0852-9. Epub 2011 Jul 1. Review.

PMID:
21720849
20.

Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies.

Kawamoto Y, Kobayashi Y, Suzuki Y, Inoue H, Tomimoto H, Akiguchi I, Budka H, Martins LM, Downward J, Takahashi R.

J Neuropathol Exp Neurol. 2008 Oct;67(10):984-93. doi: 10.1097/NEN.0b013e31818809f4.

PMID:
18800009

Supplemental Content

Support Center